CNBS
Amplify Seymour Cannabis ETF
Price Chart
Latest Quote
$29.03
| Previous Close | $27.95 |
| Open | $28.13 |
| Day High | $29.03 |
| Day Low | $27.54 |
| Volume | 3,931 |
Fund Information
| Net Assets | $86.84M |
| Expense Ratio | 0.76% |
| Category | Miscellaneous Sector |
| Fund Family | Amplify ETFs |
| Net Asset Value | $29.13 |
| Premium/Discount | -0.35% |
| P/E Ratio | 21.80 |
| Exchange | PCX |
📊 ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $nan |
| SMA50 | $nan |
| SMA200 | $nan |
| RSI | 46.16 |
| ATR | nan |
| Rel Volume | 0.57 |
Performance History
| Week | -5.47% |
| Month | +12.82% |
| Quarter | +22.80% |
| 6 Months | -24.54% |
| YTD | +0.27% |
| Year | +99.29% |
| 3 Years | -5.88% |
| 5 Years | -86.56% |
| 10 Years | -85.20% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $29.03 | 3,900 |
| 2026-06-17 | $27.95 | 2,400 |
| 2026-06-16 | $28.26 | 1,400 |
| 2026-06-15 | $28.81 | 8,500 |
| 2026-06-12 | $29.19 | 19,500 |
| 2026-06-11 | $30.71 | 7,600 |
| 2026-06-10 | $31.05 | 10,000 |
| 2026-06-09 | $31.55 | 13,200 |
| 2026-06-08 | $32.98 | 7,600 |
| 2026-06-05 | $31.61 | 18,300 |
| 2026-06-04 | $29.70 | 3,100 |
| 2026-06-03 | $27.88 | 2,200 |
| 2026-06-02 | $29.21 | 8,500 |
| 2026-06-01 | $29.55 | 10,000 |
| 2026-05-29 | $28.91 | 6,900 |
| 2026-05-28 | $29.54 | 2,700 |
| 2026-05-27 | $27.32 | 1,400 |
| 2026-05-26 | $27.31 | 3,500 |
| 2026-05-22 | $26.02 | 4,300 |
| 2026-05-21 | $26.86 | 2,200 |
| 2026-05-20 | $26.65 | 6,200 |
| 2026-05-19 | $25.73 | 14,100 |
About Amplify Seymour Cannabis ETF
Under normal market conditions, the fund seeks to achieve its investment objective by investing in the securities of U.S. companies engaged in cannabis and hemp-related activities selected by the fund’s investment adviser, Amplify Investments LL. Pursuant to this strategy, it will invest at least 80% of its net assets (plus borrowings for investment purposes) in the securities of U.S. companies that derive 50% or more of their revenue from the cannabis and hemp ecosystem and in derivatives that have economic characteristics similar to such securities. The fund is non-diversified.
📰 Latest News
US Reclassifies Weed: Can Cannabis ETFs Give Your Portfolio a New High?
Zacks • 2026-05-14T17:06:00Z
New Executive Orders Boost Weed and Psilocybin ETFs
The Daily Upside • 2026-04-27T04:01:00Z
After A Surprise Win In 2025, What Will 2026 Bring For The Amplify Cannabis ETF? | CNBS
24/7 Wall St. • 2026-01-02T16:28:55Z
Cannabis ETF (CNBS) Hits New 52-Week High
Zacks • 2025-12-18T15:16:00Z
6 Top-Performing ETF Areas of Last Week
Zacks • 2025-12-17T12:00:00Z
5 Best-Performing Leveraged ETFs of Last Week
Zacks • 2025-12-15T14:00:00Z
Cannabis ETFs Soar Double-Digits on Friday: Here's Why
Zacks • 2025-12-15T11:00:00Z
The Zacks Analyst Blog Highlights MSOS, CNBS, WEED, MJ and YOLO
Zacks • 2025-10-07T13:29:00Z
From Loss to Lift-Off: Marijuana ETFs Rebound on Legalization Prospects
Zacks • 2025-10-06T17:11:00Z
Top-Performing ETF Areas of August That Are Up At Least 20%
Zacks • 2025-09-01T12:00:00Z